HomeADPT • NASDAQ
Adaptive Biotechnologies Corp
add
$7.94
2.78%
After Hours:(0.00%)0.00
$7.94
Closed: Apr 11, 5:20:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 47.46M | 3.66% |
Operating expense | 125.93M | -12.98% |
Net income | -33.69M | 51.48% |
Net profit margin | -70.99 | 53.19% |
Earnings per share | -0.23 | 25.06% |
EBITDA | -29.39M | 26.98% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 222.29M | -35.83% |
Total assets | 539.38M | -18.42% |
Total liabilities | 336.89M | -4.52% |
Total equity | 202.49M | — |
Shares outstanding | 148.58M | — |
Price to book | 5.64 | — |
Return on assets | -15.41% | — |
Return on capital | -19.37% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -33.69M | 51.48% |
Cash from operations | -12.49M | 53.62% |
Cash from investing | 22.12M | 589.71% |
Cash from financing | 127.00K | 45.98% |
Net change in cash | 9.76M | 141.27% |
Free cash flow | 7.11M | 157.18% |
Previous close
$7.73
Day range
$7.38 - $8.30
Year range
$2.28 - $9.01
Market cap
1.18B USD
Avg Volume
2.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2009
Headquarters
Website
Employees
619